Mo B, Ding Y, Ji Q
Front Immunol. 2025; 16:1550226.
PMID: 40079000
PMC: 11896874.
DOI: 10.3389/fimmu.2025.1550226.
Wan X, Zhang H, Tian J, Liu L, An Z, Zhao X
Int J Biol Sci. 2024; 20(15):5868-5887.
PMID: 39664570
PMC: 11628330.
DOI: 10.7150/ijbs.101247.
Yuan Z, Liu Y, Wang F, Han X, Dong Z, Xing J
Rev Cardiovasc Med. 2024; 25(11):405.
PMID: 39618846
PMC: 11607496.
DOI: 10.31083/j.rcm2511405.
Papantoniou K, Aggeletopoulou I, Michailides C, Pastras P, Triantos C
Biology (Basel). 2024; 13(11).
PMID: 39596901
PMC: 11592098.
DOI: 10.3390/biology13110945.
Suthivanich P, Boonhoh W, Sumneang N, Punsawad C, Cheng Z, Phungphong S
Int J Mol Sci. 2024; 25(17).
PMID: 39273638
PMC: 11395441.
DOI: 10.3390/ijms25179692.
Neutrophil NLRP3 promotes cardiac injury following acute myocardial infarction through IL-1β production, VWF release and NET deposition in the myocardium.
Heger L, Schommer N, Van Bruggen S, Sheehy C, Chan W, Wagner D
Sci Rep. 2024; 14(1):14524.
PMID: 38914598
PMC: 11196583.
DOI: 10.1038/s41598-024-64710-4.
The role of pyroptosis in heart failure and related traditional chinese medicine treatments.
Qin J, Yang Q, Wang Y, Shi M, Zhao X, Zhou Y
Front Pharmacol. 2024; 15:1377359.
PMID: 38868667
PMC: 11168204.
DOI: 10.3389/fphar.2024.1377359.
Initial Despair and Current Hope of Identifying a Clinically Useful Treatment of Myocardial Reperfusion Injury: Insights Derived from Studies of Platelet P2Y Antagonists and Interference with Inflammation and NLRP3 Assembly.
Cohen M, Downey J
Int J Mol Sci. 2024; 25(10).
PMID: 38791515
PMC: 11122283.
DOI: 10.3390/ijms25105477.
Research progress on the improvement of cardiovascular diseases through the autonomic nervous system regulation of the NLRP3 inflammasome pathway.
Hu Y, Dai S, Zhao L, Zhao L
Front Cardiovasc Med. 2024; 11:1369343.
PMID: 38650918
PMC: 11034522.
DOI: 10.3389/fcvm.2024.1369343.
Therapeutic Role of Chinese Medicine Targeting Nrf2/HO-1 Signaling Pathway in Myocardial Ischemia/Reperfusion Injury.
Liu C, Guo X, Zhou Y, Wang H
Chin J Integr Med. 2024; 30(10):949-960.
PMID: 38329655
DOI: 10.1007/s11655-024-3657-0.
Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease.
Hu C
Nat Prod Bioprospect. 2024; 14(1):12.
PMID: 38282092
PMC: 10822835.
DOI: 10.1007/s13659-024-00432-4.
Cardioprotective Strategies After Ischemia-Reperfusion Injury.
Zhang H, Hu H, Zhai C, Jing L, Tian H
Am J Cardiovasc Drugs. 2023; 24(1):5-18.
PMID: 37815758
PMC: 10806044.
DOI: 10.1007/s40256-023-00614-4.
Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction.
Leanca S, Afrasanie I, Crisu D, Matei I, Duca S, Costache A
Life (Basel). 2023; 13(4).
PMID: 37109529
PMC: 10143569.
DOI: 10.3390/life13041000.
The potential role of SARS-CoV-2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread.
Alsaidan A, Al-Kuraishy H, Al-Gareeb A, Alexiou A, Papadakis M, Alsayed K
Immun Inflamm Dis. 2023; 11(3):e798.
PMID: 36988260
PMC: 10022425.
DOI: 10.1002/iid3.798.
Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies.
Yanpiset P, Maneechote C, Sriwichaiin S, Siri-Angkul N, Chattipakorn S, Chattipakorn N
Acta Pharm Sin B. 2023; 13(1):29-53.
PMID: 36815034
PMC: 9939317.
DOI: 10.1016/j.apsb.2022.08.007.
The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity.
Bhagat A, Shrestha P, Kleinerman E
Int J Mol Sci. 2022; 23(23).
PMID: 36498974
PMC: 9739741.
DOI: 10.3390/ijms232314649.
Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?.
Chiorescu R, Mocan M, Inceu A, Buda A, Blendea D, Vlaicu S
Int J Mol Sci. 2022; 23(21).
PMID: 36362423
PMC: 9656166.
DOI: 10.3390/ijms232113638.
Deciphering the Basis of Molecular Biology of Selected Cardiovascular Diseases: A View on Network Medicine.
AlHajri N, Rustom M, Adegbile A, Ahmed W, Kilidar S, Afify N
Int J Mol Sci. 2022; 23(19).
PMID: 36232723
PMC: 9569471.
DOI: 10.3390/ijms231911421.
Montelukast and Acute Coronary Syndrome: The Endowed Drug.
Alomair B, Al-Kuraishy H, Al-Gareeb A, Al-Hamash S, De Waard M, Sabatier J
Pharmaceuticals (Basel). 2022; 15(9).
PMID: 36145367
PMC: 9500901.
DOI: 10.3390/ph15091147.
NLRP3-mediated inflammation in cardio-oncology: sterile yet harmful.
Mauro A, Mezzaroma E, Toldo S, Melendez G, Franco R, Lesnefsky E
Transl Res. 2022; 252:9-20.
PMID: 35948198
PMC: 9839540.
DOI: 10.1016/j.trsl.2022.08.004.